Document ID: chunk:federal_register_of_legislation:F2019L01689:reg:7
Version: federal_register_of_legislation:F2019L01689
Segment Type: reg
Provision Reference: reg 7
Character Range: 1635–3224

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about Kaposi sarcoma and death from Kaposi sarcoma.
Meaning of Kaposi sarcoma
(2)          For the purposes of this Statement of Principles, Kaposi sarcoma:
(a)          means a multicentric vascular neoplasm arising from endothelial cells and characterised by the proliferation of spindle cells, formation of new blood vessels and inflammation; and
(b)          excludes soft tissue sarcoma.
Note:  Typical clinical manifestations are coloured patches, plaques or nodules on the skin, although lesions may also involve the mucous membranes, lymph nodes and viscera.
(3)          While Kaposi sarcoma attracts ICD‑10‑AM code C46, in applying this Statement of Principles the meaning of Kaposi sarcoma is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from Kaposi sarcoma
(5)          For the purposes of this Statement of Principles, Kaposi sarcoma, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's Kaposi sarcoma.
Note: terminal event is defined in the Schedule 1 – Dictionary.